Features Screener Stocks Charts
Sign In Sign Up

Cipla Ltd. Fundamental Analysis Revenue, Profits & Valuation

NSE: CIPLA | BSE: 500087 | PHARMACEUTICALS
Price ₹1,433.10 +₹17.40 (+1.23%)
P/E Ratio 29.9 TTM
52-Week Range
Low ₹1,166 High ₹1,673
Market Cap ₹1.16T Trillion
ROE 11.2% Annual

Market data as of Jun 23, 2026

Cipla Ltd. (CIPLA) gets a full breakdown here, covering its financial performance and how the market is currently pricing the stock.

Cipla Revenue Trend

Revenue grew 2.2% year-over-year, moving from ₹28,409 Cr in FY2025 to ₹29,045 Cr in FY2026.

A 7.8% CAGR over 10 years puts Cipla Ltd. in the middle of the pack on top-line growth. The company's revenue base expanded from ₹13,678 Cr to ₹29,045 Cr over that stretch.

With ₹29,045 Cr in revenue, Cipla Ltd. holds a significant position in the Indian pharmaceuticals sector.

Ten consecutive years of revenue growth is a meaningful streak. For Cipla Ltd., this reflects staying power rather than a single favorable cycle.

Revenue Trend
YearRevenueYoY %
FY2026₹29,045 Cr+2.2%
FY2025₹28,409 Cr+7.1%
FY2024₹26,521 Cr+16.6%
FY2023₹22,753 Cr+4.5%
FY2022₹21,763 Cr

View Cipla Ltd.'s full 10-year revenue trend with CAGR analysis →

Cipla Profitability

Profitability took a notable step back in FY2026, with Cipla Ltd.'s net income falling 26.7% to ₹3,862 Cr.

Net margin contracting from 18.5% to 13.3% in FY2026 points to costs running ahead of revenue over the period.

Diluted EPS for FY2026 came in at ₹48.00, a decline from ₹65.24 in the prior year.

Is Cipla Undervalued

Using the P/E Ratio model, Cipla Ltd.'s fair value works out to ₹1,443, which is 0.7% upside from the current trading price.

Cipla Ltd. shares are presently trading at ₹1,433.10.

Craytheon also calculates intrinsic value using the EPS Growth and DCF models, with the full breakdown and assumptions available in the detailed analysis.

Valuation Models
ModelEst. Fair Valuevs. Current Price
P/E Ratio₹1,4430.7% upside to fair value
EPS GrowthUpgradeUpgrade
DCFUpgradeUpgrade

See all valuation models for Cipla Ltd. with detailed assumptions →

Cipla Shareholding Pattern

Promoter holding has stayed flat at 29.2%, with no buying or selling recorded over the past 4 quarters.

Foreign investors held 23.9% of Cipla Ltd. as of December 2025, down from 26.3% a year prior.

Domestic institutions raised their stake to 30.7% from 28.1% over the past year, offsetting part of the foreign outflow.

Shareholding Pattern (Last 4 Quarters)
QuarterPromoterFIIDIIPublic
Dec 202529.2%23.9%30.7%16.1%
Sep 202529.2%24.6%30.2%16.0%
Jun 202529.2%25.2%29.3%16.3%
Mar 202529.2%26.3%28.1%16.4%

Track quarterly shareholding changes for Cipla Ltd. →

Cipla Balance Sheet

Proportional view as of 23 Jun 2026. Hover blocks for details.

Assets

Liabilities & Equity

FY2026 total assets: ₹424.96B (up 13.7% YoY from ₹373.87B).

Top categories: Cash & ST Investments (20.5%), Property, Plant & Equipment (16.9%), Other Assets (16.5%).

Of the ₹424.96B in liabilities and equity, 81.2% is shareholder equity, 1.4% is interest-bearing debt, and 17.3% is operating liabilities. Over the year, debt is up 40.1% and equity is up 10.3%.

Balance sheet composition — FY 2026

Assets (values in Indian Rupees, with M = millions, B = billions)
CategoryValue
Cash & ST Investments 86.98B
Receivables 56.20B
Inventories 65.97B
Property, Plant & Equipment 71.73B
Investments 5.44B
Intangibles & Goodwill 68.51B
Other Assets 70.14B
Liabilities and equity (values in Indian Rupees, with M = millions, B = billions)
CategoryValue
Equity 345.20B
Short-term Debt 2.32B
Long-term Debt 3.82B
Trade Payables 32.30B
Other Liabilities 41.32B

View full balance sheet (multi-year) →

What Stands Out About Cipla

Putting it all together, here is the picture Cipla Ltd. (CIPLA) presents for fundamental analysts.

FY2026 revenue came in at ₹29,045 Cr, a 2.2% increase year-over-year.

Over the past 10 years, the top line has compounded at 7.8% annually.

The company is profitable, with a net margin of 13.3% and net income of ₹3,862 Cr.

The P/E Ratio model implies 0.7% upside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.

Unlock Full Analysis

For the complete 10-year financial history with interactive charts and growth analysis, explore Cipla Ltd.'s detailed profile on Craytheon.

Related Stocks